PD-L1 deficiency within islets reduces allograft survival in mice

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Ma, Dongxia ^a   Duan, Wu ^a   Li, Yakun ^a   Wang, Zhimin ^a   Li, Shanglin ^a   Gong, Nianqiao ^a   Chen, Gang ^a   Chen, Zhishui ^a   Wan, Chidan ^a   Yang, Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; CD274 PROTEIN, MOUSE;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DONOR; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; KIDNEY CAPSULE; MALE; MEDIAN SURVIVAL TIME; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PROTEIN DEFICIENCY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; WILD TYPE MOUSE; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DEFICIENCY; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIGENS, CD274; GRAFT REJECTION; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION, HOMOLOGOUS;

EID: 84962426327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152087     Document Type: Article

References (40)

1. Linn T, Schmitz J, Hauck-Schmalenberger I, Lai Y, Bretzel RG, Brandhorst H, et al. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clinical and experimental immunology. 2006; 144(2):179-87. doi: 10.1111/j.1365-2249.2006.03066.x PMID: 16634789; PubMed Central PMCID: PMC1809653.
2. DiNorcia J, Lee MK, Harlander-Locke MP, Xia V, Kaldas FM, Zarrinpar A, et al. Damage control as a strategy to manage postreperfusion hemodynamic instability and coagulopathy in liver transplant. JAMA Surg. 2015; 150(11):1066-72. Epub 2015/08/27. doi: 10.1001/jamasurg.2015.1853 PMID: 26308380.
3. Krogstrup NV, Oltean M, Bibby BM, Nieuwenhuijs-Moeke GJ, Dor FJ, Birn H, et al. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT). BMJ open. 2015; 5(8): e007941. doi: 10.1136/bmjopen-2015-007941 PMID: 26297360.
4. Lee G, Hosgood SA, Patel MS, Nicholson ML. Hydrogen sulphide as a novel therapy to ameliorate cyclosporine nephrotoxicity. The Journal of surgical research. 2015; 197(2):419-26. doi: 10.1016/j.jss. 2015.02.061 PMID: 25990693.
5. Shoji K, Funaki T, Kasahara M, Sakamoto S, Fukuda A, Vaida F, et al. Risk factors for bloodstream infection after living-donor liver transplantation in children. Pediatr Infect Dis J. 2015; 34(10):1063-8. Epub 2015/06/30. doi: 10.1097/INF.0000000000000811 PMID: 26121201.
6. Xu DM, Yu XF, Zhang D, Zhang MX, Zhou JF, Tan PH, et al. Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice. Diabetologia. 2012; 55(4):1091-102. doi: 10.1007/s00125-011-2433-9 PMID: 22270222.
7. Huang SH, Chu CH, Yu JC, Chuang WC, Lin GJ, Chen PL, et al. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia. 2010; 53 (11):2389-400. doi: 10.1007/s00125-010-1858-x PMID: 20683574.
8. Takemoto N, Konagaya S, Kuwabara R, Iwata H. Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression. Transplantation. 2015; 99 (5):942-7. doi: 10.1097/TP.0000000000000579 PMID: 25651308.
9. Grapensparr L, Vasylovska S, Li Z, Olerud J, Jansson L, Kozlova E, et al. Co-transplantation of human pancreatic islets with post-migratory neural crest stem cells increases beta-cell proliferation and vascular and neural regrowth. The Journal of clinical endocrinology and metabolism. 2015; 100(4): E583-90. doi: 10.1210/jc.2014-4070 PMID: 25668197.
10. Jeffery LE, Qureshi OS, Gardner D, Hou TZ, Briggs Z, Soskic B, et al. Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function. PloS one. 2015; 10(7):e0131539. doi: 10.1371/journal.pone.0131539 PMID: 26134669; PubMed Central PMCID: PMC4489761.
11. Luan XY, Yu WZ, Cao QZ, Fu Q, Zhang HX. [The effects of B7H4 on human bone marrow mesenchymal stem cell inhibiting proliferation of PHA activated T cells]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2009; 30(10):689-93. PMID: 19954668.
12. Nishimura H, Agata Y, Kawasaki A, Sato M, Imamura S, Minato N, et al. Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. International immunology. 1996; 8(5):773-80. PMID: 8671666.
13. Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol. 2004; 173(2):945-54. PMID: 15240681.
14. Ozkaynak E, Wang L, Goodearl A, McDonald K, Qin S, O'Keefe T, et al. Programmed death-1 targeting can promote allograft survival. J Immunol. 2002; 169(11):6546-53. PMID: 12444166.
15. Fiorina P, Jurewicz M, Vergani A, Petrelli A, Carvello M, D'Addio F, et al. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. Journal of immunology. 2011; 186(1):121-31. doi: 10.4049/jimmunol. 1000799 PMID: 21131428; PubMed Central PMCID: PMC3404615.
16. Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, Yuan X, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation. 2008; 117(5):660-9. doi: 10.1161/CIRCULATIONAHA.107.741025 PMID: 18212277.
17. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967; 16(1):35-9. PMID: 5333500.
18. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation. 1985; 40(4):437-8. PMID: 2996187.
19. Wang X, Hao J, Metzger DL, Mui A, Ao Z, Verchere CB, et al. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation. 2009; 87 (4):482-90. doi: 10.1097/TP.0b013e318195e5fa PMID: 19307783.
20. Sakata N, Egawa S, Sumi S, Unno M. Optimization of glucose level to determine the stimulation index of isolated rat islets. Pancreas. 2008; 36(4):417-23. doi: 10.1097/MPA.0b013e31815ccad2 PMID: 18437089.
21. Bassi R, Fiorina P. Impact of islet transplantation on diabetes complications and quality of life. Current diabetes reports. 2011; 11(5):355-63. doi: 10.1007/s11892-011-0211-1 PMID: 21748256.
22. Vergani A, Fotino C, D'Addio F, Tezza S, Podetta M, Gatti F, et al. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection. Diabetes. 2013; 62(5):1665-75. doi: 10.2337/db12-0242 PMID: 23315496; PubMed Central PMCID: PMC3636636.
23. Fiorina P, Jurewicz M, Tanaka K, Behazin N, Augello A, Vergani A, et al. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival. Diabetes. 2007; 56(4):912-20. doi: 10.2337/db06-1445 PMID: 17287465.
24. Ansari MJ, Fiorina P, Dada S, Guleria I, Ueno T, Yuan X, et al. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. Clinical immunology. 2008; 126(2):140-7. doi: 10.1016/j.clim. 2007.07.019 PMID: 17889619.
25. Ben Nasr M, Vergani A, Avruch J, Liu L, Kefaloyianni E, D'Addio F, et al. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta diabetologica. 2015; 52(5):917-27. doi: 10.1007/s00592-015-0735-y PMID: 25808641.
26. Tezza S, Ben Nasr M, Vergani A, Valderrama Vasquez A, Maestroni A, Abdi R, et al. Novel immunological strategies for islet transplantation. Pharmacological research. 2015; 98:69-75. doi: 10.1016/j.phrs. 2014.06.016 PMID: 25014184.
27. Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. European journal of immunology. 2003; 33(10):2706-16. doi: 10.1002/eji.200324228 PMID: 14515254.
28. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002; 169(10):5538-45. PMID: 12421930.
29. Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, et al. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of neuroimmunology. 2004; 155(1-2):172-82. doi: 10.1016/j.jneuroim.2004.06.013 PMID: 15342209.
30. Dudler J, Li J, Pagnotta M, Pascual M, von Segesser LK, Vassalli G. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation. 2006; 82(12):1733-7. doi: 10. 1097/01.tp.0000250757.69384.79 PMID: 17198268.
31. Li T, Ma R, Zhu JY, Wang FS, Huang L, Leng XS. PD-1/PD-L1 costimulatory pathway-induced mouse islet transplantation immune tolerance. Transplantation proceedings. 2015; 47(1):165-70. doi: 10. 1016/j.transproceed.2014.10.043 PMID: 25645798.
32. El Khatib MM, Sakuma T, Tonne JM, Mohamed MS, Holditch SJ, Lu B, et al. beta-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection. Gene therapy. 2015; 22(5):430-8. doi: 10.1038/gt.2015.18 PMID: 25786871; PubMed Central PMCID: PMC4520544.
33. Plege-Fleck A, Lieke T, Romermann D, Duvel H, Hundrieser J, Buermann A, et al. Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1. Xenotransplantation. 2014; 21(6):533-42. doi: 10.1111/xen.12121 PMID: 25041075.
34. Aramaki O, Shirasugi N, Takayama T, Shimazu M, Kitajima M, Ikeda Y, et al. Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation. 2004; 77(1):6-12. doi: 10.1097/01.TP.0000108637.65091.4B PMID: 14724428.
35. Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, et al. CD28-independent costimulation of T cells in alloimmune responses. Journal of immunology. 2001; 167(1):140-6. PMID: 11418642.
36. Sho M, Yamada A, Najafian N, Salama AD, Harada H, Sandner SE, et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. Journal of immunology. 2002; 169(7):3744-51. PMID: 12244168.
37. Gao W, Demirci G, Strom TB, Li XC. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation. 2003; 76(6):994-9. doi: 10.1097/01.TP.0000085010.39567.FB PMID: 14508368.
38. Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, et al. Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clinical immunology. 2007; 125(1):16-25. doi: 10.1016/j.clim. 2007.05.013 PMID: 17627890.
39. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. Journal of immunology. 2005; 174(6):3408-15. PMID: 15749874.
40. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. The Journal of experimental medicine. 2006; 203(4):883-95. doi: 10.1084/jem.20051776 PMID: 16606670; PubMed Central PMCID: PMC2118286.